Increase of coronary flow and levels of PGE1 and PGF2 alpha from the ischemic area of experimental myocardial infarction.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000378:metabolism*; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood; D007213:Indomethacin / Q000494:pharmacology; D007773:Lactates / Q000097:blood; D009203:Myocardial Infarction / Q000378:metabolism*; D011458:Prostaglandins E / Q000097:blood*; D011460:Prostaglandins F / Q000097:blood*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D011458:Prostaglandins E; D011460:Prostaglandins F; D007213:Indomethacin